Public Employees Retirement Association of Colorado Reduces Stock Position in Phreesia, Inc. (NYSE:PHR)

Public Employees Retirement Association of Colorado decreased its position in Phreesia, Inc. (NYSE:PHR) by 8.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,551 shares of the company’s stock after selling 681 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Phreesia were worth $160,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of PHR. Vanguard Group Inc. raised its holdings in Phreesia by 4.4% in the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock worth $107,148,000 after purchasing an additional 194,035 shares in the last quarter. Champlain Investment Partners LLC bought a new stake in Phreesia during the 1st quarter valued at approximately $29,941,000. Boston Partners purchased a new position in shares of Phreesia during the 1st quarter worth approximately $669,000. Blair William & Co. IL raised its position in shares of Phreesia by 42.6% in the 1st quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after acquiring an additional 224,950 shares in the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in shares of Phreesia by 1,407.9% in the 1st quarter. Russell Investments Group Ltd. now owns 57,874 shares of the company’s stock valued at $1,385,000 after purchasing an additional 54,036 shares during the period. 92.10% of the stock is owned by institutional investors.

Phreesia Trading Up 2.3 %

Shares of NYSE:PHR opened at $22.72 on Monday. Phreesia, Inc. has a 1 year low of $12.05 and a 1 year high of $29.16. The stock’s fifty day moving average price is $24.02 and its 200-day moving average price is $22.63. The company has a market cap of $1.31 billion, a P/E ratio of -10.47 and a beta of 0.93. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. The firm had revenue of $102.12 million for the quarter, compared to the consensus estimate of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. Sell-side analysts expect that Phreesia, Inc. will post -1.23 earnings per share for the current year.

Insider Buying and Selling at Phreesia

In other news, Director Mark Douglas Smith sold 7,000 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $25.00, for a total value of $175,000.00. Following the transaction, the director now owns 30,653 shares in the company, valued at approximately $766,325. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO Evan Roberts sold 1,669 shares of the business’s stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total transaction of $39,622.06. Following the completion of the sale, the chief operating officer now owns 753,234 shares of the company’s stock, valued at approximately $17,881,775.16. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Mark Douglas Smith sold 7,000 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $25.00, for a total value of $175,000.00. Following the completion of the transaction, the director now directly owns 30,653 shares in the company, valued at $766,325. The disclosure for this sale can be found here. Insiders sold a total of 46,203 shares of company stock worth $1,129,699 in the last three months. 5.80% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $34.00 price target on shares of Phreesia in a research note on Thursday, September 5th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $23.00 price target on shares of Phreesia in a research note on Friday. JPMorgan Chase & Co. boosted their price objective on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, September 9th. KeyCorp decreased their target price on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, July 11th. Finally, Robert W. Baird boosted their price target on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research report on Friday, September 6th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.42.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.